3The effect of recombinant human endostatin combined with cisplatin on the expression of VEGF and MMP-9 of C57BL/6 mouse with sarcomaARTICLES395-398
6Expression of miR-122 in hepatocarcinoma and its relationship with cell cycle regulationARTICLES406-408
7Anterior corpectomy with small incision fixed by MACS-TL to treat the thoraco-lumbar spinal matastatic tumorARTICLES409-413
8Dose climbing trial of lobaplatin combined with 5-FU/CF in patients with advanced gastric or colorectal cancerARTICLES414-417
9The multi-factor prognostic analysis of 358 hepatocellular carcinomas with combination therapyARTICLES418-424
10Multiplicity of psychological, physiological and social function and life quality in patients with hereditary nonpolyposis colorectal carcinomaARTICLES425-428
11Clinical value of serum TPS, VEGF, CEA markers in non-small cell lung cancer patientsARTICLES429-431
12Short-term efficacy of combination chemotherathpy with pemetrexed and nedaplatin in the retreatment of advanced breast cancerARTICLES432-434
13COX-2 and response to paclitaxel liposome and epirubicin based neoadjuvant chemotherapy response in breast cancerARTICLES435-437
14Comparative study of laparoscopic gastrectomy and open gastrectomy for gastric cancerARTICLES438-440
15Clinical observation of weekly docetaxel combined with capecitabine as the second-line therapy in advanced esophageal cancerCLINICAL PRACTICE441-443
16Clinical observation of nedaplatin concurrent with radiotherapy for mid-advanced nasopharyngeal carcinoma and esophageal carcinomaCLINICAL PRACTICE444-446
17Clinical observation of conservative surgery plus radiotherapy and chemotherapy for 52 patients with early stage breast cancerCLINICAL PRACTICE447-449
18Clinical observation of continuously subcutaneous-pumped octreotide infusion in palliative treatment of malignant bowel obstructionCLINICAL PRACTICE450-452
19Clinical Study of the rh-endostatin combined with TP regimen for advanced non-small cell lung cancerANTI-ANGIOGENESIS STUDY453-456
20Promising future biomarkers for anti-EGFR monoclonal antibody in colorectal cancerREVIEW AND LECTURES457-460
